Intelligence Platform
Patents
Browse 379 pharma-relevant patents (US and EP, A61K/A61P) linked to tracked companies. Patent cliff and LOE intelligence for BD teams.
US 6406887
Compositions for diagnosing Rochalimaea henselae and Rochalmaea quintana infection
expired patentUS 6403635
Method of treating atherosclerosis or restenosis using microtubule stabilizing agent
expired patentUS 6391651
Materials and methods for detection of insulin dependent diabetes
expired patentUS 6387389
Sustained-release derivatives of hydroxylated analogs of substituted 1-[2[bis(aryl)methoxy
expired patentUS 6379660
Nitric oxide-releasing 1-[(2-carboxylato)pyrrolidin-1-yl] diazen-1-ium-1,2-diolates and co
expired patentUS 6365712
Methods and compositions for inhibiting inflammation and angiogenesis comprising a mammali
expired patentUS 6353019
Macrocyclic lactones, compositions, and methods of use
expired patentUS 6326466
Double-stranded RNA dependent protein kinase derived peptides to promote proliferation of
expired patentUS 6316190
Oligonucleotides which specifically bind retroviral nucleocapsid proteins
expired patentUS 6290963
Anti-HIV compositions containing native and recombinant peptides
expired patentUS 6165460
Generation of immune responses to prostate-specific antigen (PSA)
expired patentUS 6153421
Cloned genomes of infectious hepatitis C viruses and uses thereof
expired patentUS 6146643
Human/simian chimeric hepatitis A virus vaccine
expired patentUS 6051405
Constructs encoding recombinant antibody-toxin fusion proteins
expired patentUS 6045802
Enhanced immune response to an antigen by a composition of a recombinant virus expressing
expired patentUS 6045789
Bystander effect tumoricidal therapy by expressing an HSV-tk gene
expired patentUS 6040334
Use of inhibitors of 3-hydroxy-3-methylglutaryl coenzyme a reductase as a modality in canc
expired patentUS 6039957
Oligomeric HIV-1 envelope glycoproteins
expired patentUS 6013433
Baculovirus expression vectors and recombinant antigens for detecting type-specific antibo
expired